Investing long-term in the cell & gene therapies of the future
August 22, 2023
David McCall, Senior Editor, BioInsights, speaks to Geeta Vemuri, Founder and Managing Partner, Agent Capital, about her VC company's portfolio of advanced therapy investments, and the keys to obtaining funding in a difficult environment. (From an interview conducted on February 22nd, 2023).
What have you been working on lately?
Agent Capital’s investment strategy and advanced therapies portfolio
What are the key areas of innovation for cell and gene therapy currently?
Current and future fundraising landscape for advanced therapy biotechs
Keys to attracting investment both now and in the future
Key future goals and priorities for Agent Capital and its portfolio companies